Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, signaling a backend/UI update to the page. This change does not alter study data or content.SummaryDifference0.1%

- Check9 days agoChange DetectedA new Study Status entry was added to the record history, reflecting an update to the trial's status. An older 2026-06-11 history item was removed.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe Record History gains a new entry for Revision: v3.6.3. This signals a subsequent update to the study record's metadata on ClinicalTrials.gov.SummaryDifference0.1%

- Check31 days agoChange DetectedThe record history adds a new revision entry for Revision: v3.6.2, indicating the page was updated from v3.6.0 to v3.6.2.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history page now includes new quick-links (Check who can join, Find Contact Information) and displays an updated Study Status entry in the version list, reflecting interface enhancements to access study details.SummaryDifference1%

- Check52 days agoChange DetectedA new site revision entry (v3.5.5) was added to the history, and the previous revision (v3.5.4) was removed from the record.SummaryDifference0.1%

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.